Home » Topics » Disease categories and therapies » Immune

Immune
RSS

PADRE technology shows promise as universal vaccine immune stimulant

Jan. 26, 2000

North American Vaccine submits NeisVac-C for U.K. approval

Jan. 25, 2000

Peptide Therapeutics' C. difficile vaccine: positive phase I/II results

Jan. 25, 2000

Pfizer presents new series of JAK3 inhibitors for autoimmune diseases

Jan. 24, 2000

SmithKline Beecham signs CpG DNA immune stimulant agreement

Jan. 21, 2000

North American Vaccine to seek NeisVac-C approval in U.K. shortly

Jan. 20, 2000

QS-21 license granted to Elan

Jan. 20, 2000

Avant's cholera vaccine to enter phase IIb trial

Jan. 19, 2000

Isolation of unnamed tick-borne bacterium causing HGE patented by Aquila

Jan. 17, 2000

FDA accepts NDA for new Rapamune formulation

Jan. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...